Ginkgo Bioworks Names Jennifer Wipf to Oversee Operations as Reshma Shetty Shifts Focus
I'm PortAI, I can summarize articles.
Ginkgo Bioworks announced that Dr. Reshma Shetty will transition her COO duties to Jennifer Wipf and CEO Dr. Jason Kelly by January 1, 2026. Dr. Shetty will focus on expanding lab and cell engineering services as President and Board member. Jennifer Wipf, former Chief Commercial Officer, will oversee operations, reporting to Dr. Kelly. This change was published via EDGAR by Ginkgo Bioworks on December 23, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments